Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Tatva Chintan Pharma Chem
Start SIPTatva Chintan Pharma Chem Investment Rating
-
Master Rating:
-
Tatva Chintan Pharma Chem has an operating revenue of Rs. 423.61 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of 11% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 63 indicates it belongs to a poor industry group of Chemicals-Basic and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 119 | 114 | 84 | 86 | 102 |
| Operating Expenses Qtr Cr | 104 | 97 | 75 | 73 | 80 |
| Operating Profit Qtr Cr | 15 | 17 | 9 | 13 | 22 |
| Depreciation Qtr Cr | 3 | 2 | 2 | 2 | 2 |
| Interest Qtr Cr | 3 | 2 | 1 | 1 | 1 |
| Tax Qtr Cr | -9 | 3 | 2 | 3 | 1 |
| Net Profit Qtr Cr | 16 | 11 | 5 | 9 | 19 |
Tatva Chintan Pharma Chem Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 4
- Bearish Moving Average
- ___
- 12
- 20 Day
- ₹1653.29
- 50 Day
- ₹1702.16
- 100 Day
- ₹1821.05
- 200 Day
- ₹1988.8
- 20 Day
- ₹1642.91
- 50 Day
- ₹1666.05
- 100 Day
- ₹1832.35
- 200 Day
- ₹2103.77
Tatva Chintan Pharma Chem Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹1666.49 |
| Second Resistance | ₹1678.62 |
| Third Resistance | ₹1686.34 |
| RSI | 48.11 |
| MFI | 59.25 |
| MACD Single Line | -14.42 |
| MACD | -9.57 |
| Support | |
|---|---|
| First Resistance | ₹1646.64 |
| Second Resistance | ₹1638.92 |
| Third Resistance | ₹1626.79 |
Tatva Chintan Pharma Chem Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 8,688 | 557,422 | 64.16 |
| Week | 13,225 | 934,875 | 70.69 |
| 1 Month | 25,050 | 1,283,585 | 51.24 |
| 6 Month | 13,894 | 917,705 | 66.05 |
Tatva Chintan Pharma Chem Result Highlights
Tatva Chintan Pharma Chem Synopsis
NSE-Chemicals-Basic
Tatva Chintan Pharm is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 403.04 Cr. and Equity Capital is Rs. 22.17 Cr. for the Year ended 31/03/2023. Tatva Chintan Pharma Chem Ltd. is a Public Limited Listed company incorporated on 12/06/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ1996PLC029894 and registration number is 029894.| Market Cap | 3,659 |
| Sales | 403 |
| Shares in Float | 0.47 |
| No of funds | 31 |
| Yield | 0.12 |
| Book Value | 7.25 |
| U/D Vol ratio | 0.8 |
| LTDebt / Equity | 1 |
| Alpha | -0.16 |
| Beta | 0.82 |
Tatva Chintan Pharma Chem
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 79.17% | 79.17% | 79.17% | 79.17% |
| Mutual Funds | 10.98% | 11.12% | 10.8% | 10.34% |
| Insurance Companies | 0.53% | 0.2% | 0.17% | 0.22% |
| Foreign Portfolio Investors | 3.54% | 3.74% | 3.59% | 3.53% |
| Individual Investors | 5.09% | 5.01% | 5.49% | 6.03% |
| Others | 0.69% | 0.76% | 0.78% | 0.71% |
Tatva Chintan Pharma Chem Management
| Name | Designation |
|---|---|
| Mr. Chintan Nitinkumar Shah | Chairman & Managing Director |
| Mr. Ajaykumar Mansukhlal Patel | Whole Time Director |
| Mr. Shekhar Rasiklal Somani | Whole Time Director |
| Dr. Manher Chimanlal Desai | Independent Director |
| Mr. Subhash Ambubhai Patel | Independent Director |
| Dr. Avani Rajesh Umatt | Independent Director |
Tatva Chintan Pharma Chem Forecast
Price Estimates
Tatva Chintan Pharma Chem Corporate Action
Tatva Chintan Pharma Chem FAQs
What is Share Price of Tatva Chintan Pharma Chem ?
Tatva Chintan Pharma Chem share price is ₹1651 As on 05 June, 2023 | 01:47
What is the Market Cap of Tatva Chintan Pharma Chem ?
The Market Cap of Tatva Chintan Pharma Chem is ₹3659.5 Cr As on 05 June, 2023 | 01:47
What is the P/E ratio of Tatva Chintan Pharma Chem ?
The P/E ratio of Tatva Chintan Pharma Chem is 80.5 As on 05 June, 2023 | 01:47
What is the PB ratio of Tatva Chintan Pharma Chem ?
The PB ratio of Tatva Chintan Pharma Chem is 7.1 As on 05 June, 2023 | 01:47